YAP/TAZ-TEAD activity promotes the malignant transformation of cervical intraepithelial neoplasia through enhancing
Shu Li1, Xing Li1, Yong-Bin Yang1
1Department of Obstetrics and Gynecology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200080, China.
The Yes-associated protein (YAP)/transcriptional co-activator with PDZ-binding motif (TAZ)-transcriptional enhanced associate domain (TEAD) pathway drives cervical intraepithelial neoplasia (CIN) progression by enhancing cancer stem cell characteristics and the Warburg effect. Inhibiting this pathway offers potential for CIN diagnosis and treatment.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- The Yes-associated protein (YAP)/transcriptional co-activator with PDZ-binding motif (TAZ)-transcriptional enhanced associate domain (TEAD) pathway is recognized as a key driver in various cancers.
- The specific role and underlying mechanisms of the YAP/TAZ-TEAD pathway in the development of cervical intraepithelial neoplasia (CIN) remain largely unelucidated.
Purpose of the Study:
- To investigate the effect of YAP/TAZ-TEAD pathway activity on the development of CIN.
- To explore potential new strategies for the diagnosis and treatment of CIN based on this pathway.
Main Methods:
- Cervical tissues from CIN patients (CIN1, CIN2/3, SCC) and healthy controls were analyzed for YAP, TAZ, and TEAD expression using immunohistochemistry, qRT-PCR, and western blot.
- Cell lines (Z172, Z183) were manipulated via siRNA-mediated knockdown of YAP/TAZ and TEAD, or overexpression of YAP/TAZ (YAP-5SA).
- Cellular stemness, glycolysis, and malignant transformation were assessed using sphere formation assays, commercial kits, MTT, Transwell, scratch assays, and xenotransplantation.
Main Results:
- YAP, TAZ, and TEAD expression significantly increased in CIN2/3 and SCC tissues and cell lines compared to normal tissues.
- Knockdown of YAP/TAZ inhibited stemness, glycolysis, and malignant transformation, while YAP/TAZ activation promoted these characteristics.
- Simultaneous activation of YAP/TAZ and knockdown of TEAD attenuated the pro-malignant effects of YAP/TAZ activation.
Conclusions:
- The YAP/TAZ-TEAD signaling pathway is upregulated in CIN progression and promotes malignant transformation.
- This pathway enhances cancer stem cell characteristics and the Warburg effect, contributing to CIN development.
- Targeting the YAP/TAZ-TEAD pathway presents a promising avenue for CIN diagnosis and therapeutic intervention.
Related Concept Videos
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The Tumor Microenvironment


